Eosinophils secrete IL-4 to facilitate liver regeneration

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 24, 2013, Pages 9914-9919

  Goh, Y P Sharon ^a,b   Henderson, Neil C ^b,c   Heredia, Jose E ^b   Eagle, Alex Red ^a   Odegaard, Justin I ^d   Lehwald, Nadja ^e   Nguyen, Khoa D ^a,b   Sheppard, Dean ^b,c   Mukundan, Lata ^b   Locksley, Richard M ^b,f   Chawla, Ajay ^b  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Inflammation; Parasites; Tissue injury and repair; Type 2 immunity

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR ALPHA1; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; EOSINOPHIL; LIVER CELL; LIVER INJURY; LIVER REGENERATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

INFLAMMATION; PARASITES; TISSUE INJURY AND REPAIR; TYPE 2 IMMUNITY;

ANIMALS; CELL CYCLE; CELL PROLIFERATION; EOSINOPHILS; GENE EXPRESSION PROFILING; HEPATECTOMY; HEPATOCYTES; IMMUNOBLOTTING; INTERLEUKIN-4; INTERLEUKIN-4 RECEPTOR ALPHA SUBUNIT; LIVER; LIVER REGENERATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84878960291     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1304046110     Document Type: Article

References (34)

1. Michalopoulos GK (2010) Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol 176(1):2-13.
2. Taub R (2004) Liver regeneration: From myth to mechanism. Nat Rev Mol Cell Biol 5(10):836-847.
3. Higgins GM, Anderson RM (1931) Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol (Chic) 12:186-202.
4. Michalopoulos GK, DeFrances MC (1997) Liver regeneration. Science 276(5309):60-66.
5. Huang W, et al. (2006) Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science 312(5771):233-236.
6. Stoick-Cooper CL, Moon RT, Weidinger G (2007) Advances in signaling in vertebrate regeneration as a prelude to regenerative medicine. Genes Dev 21(11):1292-1315. (Pubitemid 46871034)
7. Allen JE, Wynn TA (2011) Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens. PLoS Pathog 7(5):e1002003.
8. Palm NW, Rosenstein RK, Medzhitov R (2012) Allergic host defences. Nature 484(7395):465-472.
9. Rosenberg HF, Dyer KD, Foster PS (2013) Eosinophils: Changing perspectives in health and disease. Nat Rev Immunol 13(1):9-22.
10. Rothenberg ME, Hogan SP (2006) The eosinophil. Annu Rev Immunol 24:147-174.
11. Heredia JE, et al. (2013) Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell 153(2):376-388.
12. Loke P, et al. (2007) Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection. J Immunol 179(6):3926-3936.
13. Baker BL, Axiotis C, Hurwitz ES, Leavitt R, Di Bisceglie AM (1991) Nodular regenerative hyperplasia of the liver in idiopathic hypereosinophilic syndrome. J Clin Gastroenterol 13(4):452-456.
14. Malyshev VV, Treshchuk LI, Popova NS (1978) [Changes in the content of eosinophils, corticosterone and catecholamines during liver regeneration following resection]. Biull Eksp Biol Med 86(12):663-664.
15. Wu D, et al. (2011) Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 332(6026):243-247.
16. Yu C, et al. (2002) Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J Exp Med 195(11):1387-1395. (Pubitemid 34602816)
17. Mitchell C, Willenbring H (2008) A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat Protoc 3(7):1167-1170.
18. Henderson NC, et al. (2006) Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci USA 103(13):5060-5065.
19. Murray PJ, Wynn TA (2011) Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11(11):723-737.
20. Anthony RM, Rutitzky LI, Urban JF, Jr., Stadecker MJ, Gause WC (2007) Protective immune mechanisms in helminth infection. Nat Rev Immunol 7(12):975-987. (Pubitemid 350166058)
21. Chen F, et al. (2012) An essential role for TH2-type responses in limiting acute tissue damage during experimental helminth infection. Nat Med 18(2):260-266.
22. Mohrs M, Shinkai K, Mohrs K, Locksley RM (2001) Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter. Immunity 15(2):303-311. (Pubitemid 32816878)
23. DeAngelis RA, et al. (2012) A complement-IL-4 regulatory circuit controls liver regeneration. J Immunol 188(2):641-648.
24. Mohrs K, Wakil AE, Killeen N, Locksley RM, Mohrs M (2005) A two-step process for cytokine production revealed by IL-4 dual-reporter mice. Immunity 23(4):419-429. (Pubitemid 41443443)
25. Finkelman FD, et al. (2004) Interleukin-4- and interleukin-13-mediated host protection against intestinal nematode parasites. Immunol Rev 201:139-155. (Pubitemid 39318449)
26. Martinez FO, Helming L, Gordon S (2009) Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27:451-483.
27. Huang W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4(1):44-57.
28. Wang X, Kiyokawa H, Dennewitz MB, Costa RH (2002) The Forkhead Box m1b transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration. Proc Natl Acad Sci USA 99(26):16881-16886. (Pubitemid 36034067)
29. Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3(1):23-35.
30. Herbert DR, et al. (2004) Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 20(5):623-635. (Pubitemid 38659504)
31. Nguyen KD, et al. (2011) Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 480(7375):104-108.
32. Medzhitov R, Schneider DS, Soares MP (2012) Disease tolerance as a defense strategy. Science 335(6071):936-941.
33. Odegaard JI, et al. (2007) Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 447(7148):1116-1120. (Pubitemid 47014427)
34. Odegaard JI, et al. (2008) Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metab 7(6):496-507. (Pubitemid 351729205)